Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

A Phase 2 study of pimavanserin for rigid-compulsive symptoms in autism spectrum disorder is currently recruiting, sponsored by the New York State Psychiatric I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pimavanserin (pimavanserin)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Autism Spectrum Disorder | Phase 2 | Status: RECRUITING